Published On: Wed, May 10th, 2017

Broker Changes For MEDIFAST INC (NYSE:MED)


Recently stock market analysts have updated their consensus ratings on shares of MEDIFAST INC (NYSE:MED).

Most recent broker ratings

08/04/2016 – MEDIFAST INC had its “hold” rating reiterated by analysts at Wunderlich. They now have a USD 36 price target on the stock.

01/11/2016 – MEDIFAST INC was upgraded to “buy” by analysts at Sidoti. They now have a USD 35 price target on the stock.

10/15/2015 – MEDIFAST INC had its “hold” rating reiterated by analysts at Canaccord Genuity. They now have a USD 31 price target on the stock.

03/03/2015 – MEDIFAST INC was downgraded to “underperform” by analysts at Bank of America Merrill Lynch.

11/07/2014 – MEDIFAST INC was downgraded to “in” by analysts at Imperial Capital. They now have a USD 32 price target on the stock.

10/07/2014 – MEDIFAST INC was upgraded to “neutral” by analysts at Zacks. They now have a USD 32.2 price target on the stock.

08/29/2014 – MEDIFAST INC had its “outperform” rating reiterated by analysts at Wedbush. They now have a USD 36 price target on the stock.

11/06/2013 – MEDIFAST INC had its “neutral” rating reiterated by analysts at Janney Montgomery Scott. They now have a USD 25 price target on the stock.

MEDIFAST INC has a 50 day moving average of 44.25 and a 200 day moving average of 42.35. The stock’s market capitalization is 558.18M, it has a 52-week low of 30.00 and a 52-week high of 47.22.

The share price of the company (NYSE:MED) was down -0.70% during the last trading session, with a high of 47.22 and the volume of MEDIFAST INC shares traded was 76383.